NRGN and Alzheimer disease: Neurogranin, a dendritic protein suggested to reflect synaptic degeneration, show increased CSF levels in early stage of AD, predict cognitive decline [6–8] and has been shown to differentiate between AD and other forms of dementia [9,10].